APA (7th ed.) Citation

R, d. C. C., M, L., C, B., K, R., A, G., S, Y., . . . F, B. (2024). Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 34(1), 191. https://doi.org/10.1007/s10286-023-01004-1

Chicago Style (17th ed.) Citation

R, de Cássia Collaço, et al. "Anxiety and Dysautonomia Symptoms in Patients with a NaV1.7 Mutation and the Potential Benefits of Low-dose Short-acting Guanfacine." Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society 34, no. 1 (2024): 191. https://doi.org/10.1007/s10286-023-01004-1.

MLA (9th ed.) Citation

R, de Cássia Collaço, et al. "Anxiety and Dysautonomia Symptoms in Patients with a NaV1.7 Mutation and the Potential Benefits of Low-dose Short-acting Guanfacine." Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society, vol. 34, no. 1, 2024, p. 191, https://doi.org/10.1007/s10286-023-01004-1.